Company research / CME

CME Group Inc. (CME)

SEC name CME GROUP INC. · CIK 0001156375 · Nasdaq · Security & Commodity Brokers, Dealers, Exchanges & Services

  • Sector Finance & Real Estate
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, CME Group Inc. reported revenue of $6.52B. Revenue grew 6.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $6.77B.

Key ratios (year ended 2025-12-31)

64.9%
Operating margin
62.5%
Net margin
14.2%
Return on year-end equity
6.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-28

Headquarters locality: Chicago / London · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 5-for-1, first reflected in a filing dated 2012-08-08. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$6.77B$6.52B$6.13B$5.58B$5.02B$4.69B$4.88B$4.87B$4.31B$3.64B$3.60B
Operating Income$4.41B$4.23B$3.93B$3.44B$3.02B$2.65B$2.64B$2.59B$2.61B$2.31B$2.20B
Depreciation & Amortizationn/a$107.50M$115.10M$126.00M$134.90M$147.80M$153.20M$158.60M$118.70M$113.00M$129.20M
EBITDAn/a$4.34B$4.05B$3.56B$3.15B$2.79B$2.79B$2.75B$2.73B$2.42B$2.33B
Net Income$4.29B$4.07B$3.53B$3.23B$2.69B$2.64B$2.11B$2.12B$1.96B$4.06B$1.53B
EPS (Diluted)n/a$11.16$9.67$8.86$7.40$7.29$5.87$5.91$5.71$11.94$4.53
Total Assets$194.68B$198.42B$137.45B$129.71B$174.18B$196.78B$124.66B$75.22B$77.48B$75.79B$69.37B
Total Liabilities$168.16B$169.70B$110.96B$102.97B$147.30B$169.38B$98.31B$49.06B$51.51B$53.38B$49.03B
Shareholders' Equity$26.52B$28.73B$26.49B$26.74B$26.88B$27.40B$26.32B$26.13B$25.92B$22.41B$20.34B
Cash & Equivalents$2.14B$4.42B$2.89B$2.91B$2.72B$2.83B$1.63B$1.55B$1.37B$1.90B$1.87B
Operating Cash Flow$4.31B$4.28B$3.69B$3.45B$3.06B$2.40B$2.72B$2.67B$2.44B$1.75B$1.73B
Capital Expenditures$96.30M$83.50M$94.00M$76.40M$89.70M$127.20M$197.50M$245.60M$116.70M$81.90M$91.80M
Free Cash Flow$4.21B$4.19B$3.60B$3.38B$2.97B$2.28B$2.52B$2.43B$2.32B$1.67B$1.64B
Dividends Paid$4.08B$3.93B$3.58B$3.24B$2.63B$2.19B$2.11B$1.70B$2.15B$1.99B$1.79B
Dividends Per Sharen/a$5.00$10.40$9.65$8.50$5.90$5.90$5.50$4.55$6.14$5.65
Weighted Average Diluted Sharesn/a360.31M359.94M359.50M359.18M358.93M358.52M358.24M343.74M340.23M338.97M
EPS (Basic)n/a$11.18$9.69$8.87$7.41$7.30$5.88$5.93$5.73$12.00$4.55

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView